You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Attention Score in Context
| Title |
A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis — A phase I clinical trial
|
|---|---|
| Published in |
Frontiers in Medicine, October 2022
|
| DOI | 10.3389/fmed.2022.1023224 |
| Pubmed ID | |
| Authors |
Stephan Thurau, Christoph M. E. Deuter, Arnd Heiligenhaus, Uwe Pleyer, Joachim Van Calster, Talin Barisani-Asenbauer, Franz Obermayr, Stefan Sperl, Romana Seda-Zehetner, Gerhild Wildner |
Attention Score in Context
This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 March 2024.
All research outputs
#1,195,164
of 25,455,127 outputs
Outputs from Frontiers in Medicine
#334
of 7,206 outputs
Outputs of similar age
#26,555
of 442,057 outputs
Outputs of similar age from Frontiers in Medicine
#17
of 512 outputs
Altmetric has tracked 25,455,127 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,206 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,057 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 512 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.